EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1–3, and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) but Does Not Alter IL-17 Levels in Whole-Blood Cultures of Patients with Spondyloarthritis

Borisz Varga, Gergely Toldi iD, László Vécsei, Yvette Mándi iD, Attila Balog

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms262411801 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Borisz Varga und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rheumatology and Immunology, University of Szeged, 6725 Szeged, Hungary. Hauptthemen laut MEDLINE: Tumor Necrosis Factor-alpha, Interleukin-17, Kynurenic Acid, Cell Adhesion Molecules. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Hungarian Association of Rheumatology 2024., The Research Grant of the Hungarian Association of Rheumatology 2024.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kynurenic acid (KYNA) has recognized anti-inflammatory and immunosuppressive properties. Previous studies demonstrated that KYNA reduces TNF-α, S100A12, S100A8/9, and α-defensin production while increasing tumor necrosis factor-stimulated gene-6 protein (TSG-6) levels in rheumatoid arthritis. This study evaluated a synthetic KYNA analog’s effects on TNF-α, S100A8/9, S100A12, α-defensin, and interleukin-17 (IL-17) production and TSG-6 expression in ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Peripheral blood mononuclear cells from 54 AS and 38 PsA patients and 11 healthy controls were stimulated with heat-inactivated Staphylococcus aureus (SA1). Parallel cultures were pretreated with the KYNA analog. Cytokine and alarmin concentrations were measured by ELISA. SA1 stimulation increased TNF-α, TSG-6, calprotectin, and α-defensin production, with minimal effects on S100A12 and none on IL-17. The KYNA analog significantly reduced SA1-induced TNF-α, calprotectin, and α-defensin levels and enhanced TSG-6 production, without affecting S100A12 or IL-17. Notably, the TNF-α inhibitory and TSG-6 stimulatory effects were inversely correlated. Conclusion: KYNA analogs may exert anti-inflammatory effects via TSG-6 upregulation, contributing to the suppression of key cytokines. These findings support further exploration of KYNA derivatives as therapeutic options in immune-mediated diseases including AS and PsA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tumor Necrosis Factor-alphaInterleukin-17Kynurenic AcidCell Adhesion MoleculesSpondylitis, AnkylosingHumansMaleAdultFemaleMiddle AgedCalgranulin Balpha-DefensinsS100A12 ProteinLeukocytes, MononuclearCalgranulin ALeukocyte L1 Antigen Complex

Stichwörter der Autor:innen

HNP1–3TNFα-stimulated gene-6TSG-6alpfa-defensincalgranulinsinterleukine-17kynurenic acidkynureninespondyloarthritis

Substanzen

Tumor Necrosis Factor-alphaInterleukin-17Kynurenic AcidTNFAIP6 protein, humanCalgranulin Balpha-DefensinsCell Adhesion MoleculesS100A12 ProteinCalgranulin ALeukocyte L1 Antigen Complex

Autor:innen und Institutionen

  • Department of Rheumatology and Immunology, University of Szeged, 6725 Szeged, Hungary.
  • Liggins Institute, University of Auckland, Auckland 1023, New Zealand.
  • Department of Neurology, University of Szeged, 6725 Szeged, Hungary.
  • Department of Medical Microbiology, University of Szeged, 6720 Szeged, Hungary.

ORCID-Profile: Gergely Toldi, Yvette Mándi

Förderung

  • Hungarian Association of Rheumatology 2024.
  • The Research Grant of the Hungarian Association of Rheumatology 2024

Zitieren

APA

Varga, B., Toldi, G., Vécsei, L., Mándi, Y., & Balog, A. (2025). Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1–3, and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) but Does Not Alter IL-17 Levels in Whole-Blood Cultures of Patients with Spondyloarthritis. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms262411801

Vancouver

Varga B, Toldi G, Vécsei L, Mándi Y, Balog A. Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1–3, and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) but Does Not Alter IL-17 Levels in Whole-Blood Cultures of Patients with Spondyloarthritis. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms262411801

BibTeX
@article{Varga2025,
  author = {Varga, Borisz and Toldi, Gergely and Vécsei, László and Mándi, Yvette and Balog, Attila},
  title = {Kynurenic Acid Analog Attenuates the Production of Tumor Necrosis Factor-α, Calgranulins (S100A 8/9 and S100A 12), and the Secretion of HNP1–3, and Stimulates the Production of Tumor Necrosis Factor-Stimulated Gene-6 (TSG-6) but Does Not Alter IL-17 Levels in Whole-Blood Cultures of Patients with Spondyloarthritis},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms262411801}
}
Kostenlos starten →